Approval · Notice of Compliance 9589 · 2008
ACZONE: Notice of Compliance 9589
Issued June 5, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9589
- Date
- June 5, 2008
- Company
- Qlt Usa, Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Anti-acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACZONE | Not yet assigned | — |
Medicinal ingredients
- DAPSONE 5 PER